XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Changes in Shareholders' Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Preferred Stock
Common Stock
Surplus
Retained Earnings
Accumulated Other Comprehensive Loss
Comprehensive Income
Balance at Dec. 31, 2008 $ 244,928   $ 28,127 $ 166,815 $ 59,171 $ (9,185)  
Balance (in shares) at Dec. 31, 2008     11,250,603        
Comprehensive income:              
Net income 13,595       13,595   13,595
Other comprehensive income, net of tax effects              
Pension and retiree medical plan 1,279         1,279 1,279
Change in pension liability for plan curtailment 1,283         1,283 1,283
Change in net unrealized gain on securities available for sale 4,795         4,795 4,795
Noncredit portion of other-than-temporary impairment losses recognized in earnings (3,540)         (3,540) (3,540)
Change in unrealized losses on derivative financial instruments qualifying as cash flow hedges (14)         (14) (14)
Total comprehensive income 17,398           17,398
Cash dividends on Series T preferred stock at annual dividend rate of 5% (1,115) 3,559     (4,674)    
Cash dividends declared at $.68 per share (8,177)       (8,177)    
Issuance of Series T preferred stock, net of issuance costs 64,632 61,220   3,412      
Issuance of Series T preferred stock (in shares)   64,779          
Repurchase of Series T preferred stock and warrants (66,179) (64,779)   (1,400)      
Repurchase of Series T preferred stock and warrants (in shares)   (64,779)          
Stock options exercised 532   77 455      
Stock options exercised (in shares)     30,831        
Employee stock purchases 566   70 496      
Employee stock purchases (in shares)     27,991        
Restricted stock awards     224 (224)      
Restricted stock awards (in shares)     89,431        
Common stock repurchased (446)   (40) (406)      
Common stock repurchased (in shares)     (15,823)        
Share-based compensation expense 1,431     1,431      
Common stock issued in public offering 29,249   3,391 25,858      
Common stock issued in public offering (in shares)     1,356,500        
Balance at Dec. 31, 2009 282,819   31,849 196,437 59,915 (5,382)  
Balance (in shares) at Dec. 31, 2009     12,739,533        
Comprehensive income:              
Net income 51,882       51,882   51,882
Other comprehensive income, net of tax effects              
Pension and retiree medical plan (514)         (514) (514)
Change in net unrealized gain on securities available for sale (1,041)         (1,041) (1,041)
Noncredit portion of other-than-temporary impairment losses recognized in earnings 3,540         3,540 3,540
Change in unrealized losses on derivative financial instruments qualifying as cash flow hedges (395)         (395) (395)
Total comprehensive income 53,472           53,472
Cash dividends declared at $.68 per share (8,680)       (8,680)    
Stock options exercised 307   41 266      
Stock options exercised (in shares)     16,220        
Employee stock purchases 669   56 613      
Employee stock purchases (in shares)     22,371        
Restricted stock awards     57 (57)      
Restricted stock awards (in shares)     22,971        
Common stock repurchased (255)   (18) (237)      
Common stock repurchased (in shares)     (7,272)        
Share-based compensation expense 1,625     1,625      
Balance at Dec. 31, 2010 329,957   31,985 198,647 103,117 (3,792)  
Balance (in shares) at Dec. 31, 2010 12,793,823   12,793,823        
Comprehensive income:              
Net income 22,595       22,595   22,595
Other comprehensive income, net of tax effects              
Pension and retiree medical plan (3,007)         (3,007) (3,007)
Change in net unrealized gain on securities available for sale 4,501         4,501 4,501
Change in unrealized losses on derivative financial instruments qualifying as cash flow hedges (451)         (451) (451)
Total comprehensive income 23,638           23,638
Cash dividends declared at $.68 per share (9,514)       (9,514)    
Stock options exercised 731   109 622      
Stock options exercised (in shares)     43,533        
Employee stock purchases 693   67 626      
Employee stock purchases (in shares)     26,838        
Restricted stock awards     144 (144)      
Restricted stock awards (in shares)     57,641        
Common stock repurchased (342)   (29) (313)      
Common stock repurchased (in shares)     (11,445)        
Share-based compensation expense 1,777     1,777      
Common stock issued in private placement offering 34,840   2,823 32,017      
Common stock issued in private placement offering (in shares)     1,129,032        
Balance at Dec. 31, 2011 $ 381,780   $ 35,099 $ 233,232 $ 116,198 $ (2,749)  
Balance (in shares) at Dec. 31, 2011 14,039,422   14,039,422